Stakeholder views on the implementation of the UK’s Antimicrobial Resistance (AMR) National Action Plan (2019–2024) in relation to AMR in the environment
Although we do not know the impact environmental exposure plays in driving clinical AMR infections relative to other sources, evidence suggests that exposure to environmental and wastewater sources may play a role, and thus requires policy interventions. Government leadership is critical for ensuring the uptake of environmental AMR research to inform mitigation and interventions based on the precautionary principle.
Authors
- Andrew C. Singer (ORCID: https://orcid.org/0000-0003-4705-6063)
- Nicholas Mays (ORCID: https://orcid.org/0000-0001-9808-8466)
- R. E. Glover (ORCID: https://orcid.org/0000-0001-9150-9977)
- Holly J. Tipper (ORCID: https://orcid.org/0000-0002-1857-9204)
- Agata Pacho (ORCID: https://orcid.org/0000-0002-0653-5095)
- Isobel C. Stanton
Institutions
- London School of Hygiene & Tropical Medicine (GB)
- UK Centre for Ecology & Hydrology (GB)
Publication Details
- Journal
- Global Health Action
- Published
- 2025-08-28
- DOI
- https://doi.org/10.1080/16549716.2025.2543101
- Primary Topic
- Pharmaceutical and Antibiotic Environmental Impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute for Health and Care Research
- Department of Health and Social Care
- Royal Veterinary College